Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Transpl Int. 2020 Oct;33(10):1199-1210. doi: 10.1111/tri.13668. Epub 2020 Jun 23.
Kidney paired donation (KPD) is a valuable tool to overcome immunological barriers in living donor transplantation. While small national registries encounter difficulties in finding compatible matches, multi-national KPD may be a useful strategy to facilitate transplantation. The Czech (Prague) and Austrian (Vienna) KPD programs, both initiated in 2011, were merged in 2015. A bi-national algorithm allowed for ABO- and low-level HLA antibody-incompatible exchanges, including the option of altruistic donor-initiated domino chains. Between 2011 and 2019, 222 recipients and their incompatible donors were registered. Of those, 95.7% (Prague) and 67.9% (Vienna) entered into KPD registries, and 81 patients received a transplant (95% 3-year graft survival). Inclusion of ABO-incompatible pairs in the Czech program contributed to higher KPD transplant rates (42.6% vs. 23.6% in Austria). After 2015 (11 bi-national match runs), the median pool size increased to 18 pairs, yielding 33 transplants (8 via cross-border exchanges). While matching rates doubled in Austria (from 9.1% to 18.8%), rates decreased in the Czech program, partly due to implementation of more stringent HLA antibody thresholds. Our results demonstrate the feasibility of merging small national KPD programs to increase pool sizes and may encourage the implementation of multi-national registries to expand the full potential of KPD.
肾联合捐献(KPD)是克服活体供者移植中免疫障碍的一种有价值的工具。虽然小型国家注册中心在寻找匹配供者方面遇到困难,但多国 KPD 可能是促进移植的一种有用策略。捷克(布拉格)和奥地利(维也纳)的 KPD 项目均于 2011 年启动,于 2015 年合并。一个双边算法允许 ABO 和低水平 HLA 抗体不相容的交换,包括利他主义供者发起的多米诺骨牌链的选择。2011 年至 2019 年间,有 222 名受者及其不相容供者登记。其中,95.7%(布拉格)和 67.9%(维也纳)进入 KPD 注册中心,81 名患者接受了移植(95%3 年移植物存活率)。捷克项目中包含 ABO 不相容对有助于提高 KPD 移植率(42.6%比奥地利的 23.6%)。2015 年(11 次双边匹配运行)后,配对池的中位数增加到 18 对,产生 33 次移植(8 次通过跨境交换)。虽然奥地利的匹配率翻了一番(从 9.1%增加到 18.8%),但捷克项目的匹配率却下降了,部分原因是 HLA 抗体阈值更加严格。我们的结果表明,合并小型国家 KPD 项目以增加配对池大小是可行的,这可能鼓励实施多国注册以充分发挥 KPD 的潜力。